1. Jiang, B J, Zhan, X L, Fu, C Z, Cheng, G, Zan, L S. 2012. Identification of ANAPC13 gene polymorphisms associated with body measurement traits in Bos taurus. In Genetics and molecular research : GMR, 11, 2862-70. doi:. https://pubmed.ncbi.nlm.nih.gov/22782628/
2. Shi, Yun, Zhang, Wencan, Jia, Qiong, Kuo, Ya-Huei, Sun, Zuoming. 2024. Cancer-associated SF3B1-K700E mutation controls immune responses by regulating Treg function via aberrant Anapc13 splicing. In Science advances, 10, eado4274. doi:10.1126/sciadv.ado4274. https://pubmed.ncbi.nlm.nih.gov/39303038/
3. Sens-Abuázar, Carolina, Napolitano E Ferreira, Elisa, Osório, Cynthia Aparecida Bueno Toledo, Rocha, Rafael Malagoli, Carraro, Dirce Maria. 2012. Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast. In Translational oncology, 5, 113-23. doi:. https://pubmed.ncbi.nlm.nih.gov/22496928/
4. Abohalawa, Bushra Yasin, Shaath, Hibah, Elango, Ramesh, Akhtar, Mohammed, Alajez, Nehad M. 2024. MicroRNAome profiling of breast cancer unveils hsa-miR-5683 as a tumor suppressor microRNA predicting favorable clinical outcome. In Cancer cell international, 24, 377. doi:10.1186/s12935-024-03550-8. https://pubmed.ncbi.nlm.nih.gov/39538254/
5. Cavalli, M, Diamanti, K, Pan, G, Komorowski, J, Wadelius, C. . A non-coding cancer mutation disrupting an HNF4α binding motif affects an enhancer regulating genes associated to the progression of liver cancer. In Experimental oncology, 43, 2-6. doi:. https://pubmed.ncbi.nlm.nih.gov/33785712/
智鼠故事 
